Year: 2021

PyroGenesis Announces Q3 2021 Results: Revenues $9.3MM; Gross Margin 43.5%; Current Backlog of Signed and/or Awarded Contracts $44.9MM

Written by Customer Service on November 16, 2021. Posted in Earnings Releases And Operating Results.

MONTREAL, Nov. 15, 2021 (GLOBE NEWSWIRE) — PyroGenesis Canada Inc. (http://pyrogenesis.com) (NASDAQ: PYR) (TSX: PYR) (FRA: 8PY), a high-tech Company (hereinafter referred to as the “Company” or “PyroGenesis”), that designs, develops, manufactures and commercializes advanced plasma processes and sustainable solutions to reduce greenhouse gases (“GHG”), is pleased to announce today its financial and operational results for the third quarter ended September 30, 2021. “We are proud to announce our Q3 2021 financials which now include the results of our recent acquisition, Pyro Green-Gas, (formerly known as AirScience Technologies Inc.). Revenues for the quarter are a historic $9.3MM as compared to $8.1MM in Q3 2020. Of note, this is the fifth quarter in a row that PyroGenesis has posted more revenues for the quarter than full year...

Burning Rock Reports Third Quarter 2021 Financial Results

Written by Customer Service on November 16, 2021. Posted in Earnings Releases And Operating Results.

GUANGZHOU, China, Nov. 15, 2021 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today reported financial results for the three months ended September 30, 2021. Business UpdatesEarly Detection 6-cancer product: we have successfully signed contracts with a small number of pilot hospitals in China for the commercialization of our 6-cancer early detection product, and will focus on customer education and contracting more hospitals. 9-cancer product: we expect our 9-cancer early detection product development read-out in the first half of 2022, with potential performance improvement over that of our 6-cancer early detection product.Pharma ServicesPharma service...

Farmers & Merchants Bancorp (FMCB) Announces Increase to the Year-End Cash Dividend

Written by Customer Service on November 16, 2021. Posted in Dividend Reports And Estimates.

LODI, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) — Farmers & Merchants Bancorp (OTCQX: FMCB) (the “Company” or “FMCB”), the parent company of Farmers & Merchants Bank of Central California, also known as F&M Bank, announced that the Board of Directors declared a year-end cash dividend of $7.80 per share, an increase of 4.00% over the cash dividend declared in November of 2020. The cash dividend will be payable on January 3, 2022 to shareholders of record as of December 9, 2021. Total cash dividends declared in 2021 increased 3.73% to $15.30 per share compared with $14.75 declared in 2020. Kent A. Steinwert, Chairman, President and Chief Executive Officer stated, “We are pleased that Farmers & Merchants Bancorp’s record third quarter and year-to-date 2021 financial performance allowed us to increase the year-end...

Biogen Announces Alfred W. Sandrock, Jr. to Retire as Head of Research & Development

Written by Customer Service on November 16, 2021. Posted in Public Companies.

CAMBRIDGE, Mass., Nov. 15, 2021 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) announced today that Alfred “Al” W. Sandrock, Jr., M.D., Ph.D., Head of Research & Development, will retire from the Company effective December 31, 2021. A 23-year veteran of Biogen, Dr. Sandrock, 64, led the development of many of the Company’s most important and transformational therapies in neurological diseases, including Tysabri® (natalizumab), Tecfidera® (dimethyl fumarate), Spinraza® (nusinersen), Plegridy® (peginterferon beta-1a) and Aduhelm™ (aducanumab-avwa). Dr. Sandrock served on Biogen’s Executive Committee since 2015, as Head of Research & Development since October 2019, and as Chief Medical Officer from 2012 to 2020. Priya Singhal, M.D., M.P.H., Head of Global Safety and Regulatory Sciences, also with oversight responsibility...

Farmers & Merchants Bancorp (FMCB) Announces Appointment of New Shareholder Relations Officer and Reauthorization of Share Repurchase Program

Written by Customer Service on November 16, 2021. Posted in Public Companies.

LODI, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) — Farmers & Merchants Bancorp (OTCQX: FMCB) (the “Company” or “FMCB”), the parent company of Farmers & Merchants Bank of Central California, also known as F&M Bank, announced that Michelle Galvan has joined the Company as Assistant Vice President and Shareholder Relations Officer. Kent A. Steinwert, Chairman, President and Chief Executive Officer stated, “Our shareholders are very important to the Company with many shareholders holding shares through several generations. We feel it is important to have a dedicated resource to meet our shareholders’ needs.” Michelle, who can be reached at 209-367-2348 or mgalvan@fmbonline.com, can assist shareholders with:facilitating the buying or selling shares; obtaining information on the Company’s current stock price or announced...

Rani Therapeutics Reports Third Quarter 2021 Financial Results, Provides Corporate Update

Written by Customer Service on November 16, 2021. Posted in Public Companies.

SAN JOSE, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical stage biotherapeutics company focused on the oral delivery of biologics, today reported financial results for the quarter ended September 30, 2021, and provided a corporate update. “I am pleased with the progress Rani has made since our IPO. As we build a solid foundation for being a successful public company, we are laser focused on creating value and achieving our milestones,” said Talat Imran, Chief Executive Officer of Rani Therapeutics. “Looking ahead, I’m excited about this important and exciting next phase as we prepare for additional clinical studies with the RaniPill™ capsule, including our Phase I study with Parathyroid Hormone planned for 2022.” Third Quarter 2021 and Subsequent...

AnaptysBio To Present at the 2021 Jefferies London Healthcare Conference

Written by Customer Service on November 16, 2021. Posted in Public Companies.

SAN DIEGO, Nov. 15, 2021 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on emerging immune control mechanisms applicable to inflammation and immuno-oncology indications, today announced that Hamza Suria, chief executive officer of AnaptysBio, will present an overview of AnaptysBio at the 2021 Jefferies London Healthcare Conference. The presentation will be available on Thursday, November 18, 2021, at 3:00 a.m. ET via https://wsw.com/webcast/jeff201/anab/1800252 A webcast of the presentation will also be available through the investor section of the AnaptysBio website at https://ir.anaptysbio.com/events. A replay of the webcast will be available for 30 days following the event. About AnaptysBio AnaptysBio is a clinical-stage...

Todos Medical Reports Third Quarter 2021 Business and Financial Results

Written by Customer Service on November 16, 2021. Posted in Earnings Releases And Operating Results.

New York, NY, and Tel Aviv, ISRAEL, Nov. 15, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical, Ltd. (“Todos Medical”) (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, announced financial results today for the third quarter ended September 30, 2021. Corporate Highlights Integration of COVID-19 PCR automation at recently acquired CLIA/CAP lab Provista drives revenues Provista is our CLIA/CAP diagnostic testing laboratory in Alpharetta, GA currently performing PCR testing for (1) COVID-19, (2) COVID variant screening and (3) respiratory pathogen panel (RPP) testing, as well as (4) cPass neutralizing antibody blood test. The integration of the automation prepared the Company to handle increased demand heading into the fourth quarter of 2021. When at full capacity the lab has automation...

Energem Corp. Announces Pricing of $100,000,000 Initial Public Offering

Written by Customer Service on November 16, 2021. Posted in Public Companies.

Kuala Lumpur, Malaysia, Nov. 15, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Energem Corp. (the “Company”) announced today that it priced its initial public offering of $100 million, consisting of 10,000,000 units at $10.00 per unit. The units will be listed on the Nasdaq Global Market (“Nasdaq”) and are expected to begin trading tomorrow, Tuesday, November 16, 2021, under the ticker symbol “ENCPU”. Each unit consists of one the Company’s Class A ordinary shares and one redeemable warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “ENCP” and “ENCPW,” respectively. The Company is a blank check company formed for...

InterCure Announces Record Third Quarter Financial Results with 3 Times YoY Revenue Growth and 36% QoQ Growth

Written by Customer Service on November 16, 2021. Posted in Earnings Releases And Operating Results.

Rapid Revenue and EBITDA Growth*Amounts shown are in CADSeventh consecutive quarter of high double-digit, sequential revenue growth Annualized revenues run rate of $100 million Adjusted EBITDA1 run rate of $23 million $85 million in cash Revenue growth expected to continue in the 4th quarter and throughout 2022 NEW YORK and TORONTO and HERZLIYA, Israel, Nov. 15, 2021 (GLOBE NEWSWIRE) — InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)(“InterCure” or the “Company”) today announced financial results for the third quarter of 2021 and is pleased to provide shareholders with a business update. All amounts are expressed in Canadian dollars ($) or New Israeli Shekels (NIS), unless otherwise noted. Third Quarter 2021 and Recent Financial & Operating HighlightsAll-time record quarterly...

Year: 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals